Question 20

The generic name for Strattera is at risk of being confused with atorvastatin.

Strattera's generic name is atomoxetine, which has a similar phonetic structure to atorvastatin, increasing the likelihood of confusion between the two medications.

A) atorvastatin

Atorvastatin is a cholesterol-lowering medication whose name bears phonetic similarities to atomoxetine. This similarity in sound can lead to potential medication errors, as healthcare providers or patients may misinterpret prescriptions or medication labels, making this option correct.

B) dapagliflozin

Dapagliflozin is a medication used to manage diabetes and does not share phonetic characteristics with atomoxetine. The distinctiveness of its name reduces the risk of confusion with Strattera, making this option incorrect.

C) rivaroxaban

Rivaroxaban, an anticoagulant, has a different phonetic structure compared to atomoxetine. The lack of similarity in sound and visual presentation makes it less likely to be confused with Strattera, thus this option is incorrect.

D) famotidine

Famotidine is a medication used to treat stomach ulcers and acid reflux. Its name does not resemble atomoxetine closely enough to pose a significant risk of confusion, leading to this option being incorrect.

Conclusion

The potential for confusion between atomoxetine and atorvastatin is significant due to their similar phonetic structures, making atorvastatin the correct answer. In contrast, the other options do not present the same risk, as their names differ sufficiently from Strattera's generic name. This highlights the importance of careful medication naming to avoid errors in clinical practice.